Back to calendar
Xilio Therapeutics, Inc. (XLO) Earnings
XLO reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.82
Actual EPS: $-0.33
Company overview
Market Cap$58.4M
SectorHealth Technology
IndustryPharmaceuticals: Major